Evaluating the Efficacy of Employing Local Anesthetic Prostatic Blocks During Rezum Procedure
- PMID: 36321018
- PMCID: PMC9599892
- DOI: 10.7759/cureus.29598
Evaluating the Efficacy of Employing Local Anesthetic Prostatic Blocks During Rezum Procedure
Abstract
Introduction Rezum is a minimally invasive, outpatient procedure using convective water vapor to relieve outlet obstruction from benign prostatic hyperplasia (BPH). Evidence on the technical approach of Rezum therapy, particularly pain control, is lacking. The purpose of this study was to evaluate the efficacy of utilizing a local anesthetic prostate block for postoperative pain control during Rezum therapy for BPH. A multimodal approach is typically utilized for pain control during and after Rezum. However, little is known about which elements are most critical. Methods This is a single-center retrospective study of 109 patients who underwent Rezum for BPH. Patients were then divided into two groups: Local anesthetic prostatic block verse no local anesthetic prostatic block for the procedure. A phone survey was performed to assess the patients' subjective pain scores and postoperative analgesics usage. A comparison of reported pain scores on a 0-10 Likert scale as well as usage of prescription and non-prescription analgesics medications was performed. Results There were 109 patients who underwent Rezum therapy, and 86 (79%) of patients responded to phone surveys. There was no significant difference in postoperative pain scores between patients who received local anesthetic prostatic block vs those who did not (2.10 vs 3.03). Similarly, there were no significant differences in postoperative narcotics or non-prescription analgesic medications usage. Conclusion Our data suggest that when performing Rezum using conscious sedation in the operating room or cystoscopy suite, it is unnecessary to perform a local anesthetic prostate block as it has no significant effect on patient-reported pain or the use of analgesics in the postoperative period.
Keywords: benign prostatic hyperplasia; pain management; prostate block; prostatic hyperplasia; rezum therapy.
Copyright © 2022, Gilpin et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- The Rezūm system - a minimally invasive water vapor thermal therapy for obstructive benign prostatic hyperplasia. Cantrill CH, Zorn KC, Elterman DS, Gonzalez RR. https://sanomedrezum.com/wp-content/uploads/2019/06/7-The-Rezum-System.pdf. Can J Urol. 2019;26:9787–9793. - PubMed
-
- Office-based therapies for benign prostatic hyperplasia: a review and update. Das AK, Leong JY, Roehrborn CG. https://europepmc.org/article/med/31481142. Can J Urol. 2019;26:2–7. - PubMed
-
- Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm(®) system: evaluation of acute ablative capabilities in the human prostate. Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Res Rep Urol. 2015;7:13–18. - PMC - PubMed
-
- Anesthesia-free procedures for benign prostate obstruction: worth it? Ebbing J, Bachmann A. Curr Opin Urol. 2015;25:32–39. - PubMed
-
- Periprostatic nerve blockage reduces postoperative analgesic consumption and pain scores of patients undergoing transurethral prostate resection. Gorur S, Inanoglu K, Akkurt BC, Candan Y, Kiper AN. Urol Int. 2007;79:297–301. - PubMed
LinkOut - more resources
Full Text Sources